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To the Editor:
I read the review article “First- and Second-trimester
Down Syndrome Screening: Current Strategies and
Clinical Guidelines” with great pleasure [1]. The first
sentence started with “Down syndrome is the most
common human disease caused by a structural chro-
mosome defect.” It raised a major question, and I
quote a sentence from Wikipedia for comparison,
“Named after John Langdon Down, the first physician
to identify the syndrome, Down syndrome is the most
frequent genetic cause of mild to moderate mental
retardation and associated medical problems and occurs
in one out of 800 live births, in all races and economic
groups.”
Down syndrome is a well known chromosomal dis-
order caused by an error in cell division that results 
in the presence of an additional third chromosome 21
or “trisomy 21” (in approximately 92% of all cases of
Down syndrome) [2]. A genetic disorder is caused by
an altered or faulty gene or set of genes. Over 1,000
known disorders are caused by chromosomal abnormal-
ities. Chromosomal abnormalities can include changes
in number, changes in structure, uniparental disomy,
and mosaicism. Down syndrome, or trisomy 21, is an
example of a condition caused by numerical abnormal-
ities (three copies of chromosome 21). Turner syndrome
is an example of monosomy, where the individual (in
this case a female) is born with only one sex chro-
mosome, an X. Structural abnormalities include dele-
tions, duplications, translocations, inversions, and rings.
Approximately 2–4% of Down syndrome cases are due
to mosaic trisomy 21 and approximately 3–4% are due
to translocation trisomy 21. Therefore, most cases of
Down syndrome are not caused by structural abnor-
malities. In 88% of cases, the extra copy of chromo-
some 21 is derived from the mother, in 8% of the cases,
the extra copy comes from the father, and in the remain-
ing 2% of cases, Down syndrome is due to mitotic errors
[2]. The rising incidence of Down syndrome with increas-
ing maternal age is well known. The likelihood that a
woman under 30 who becomes pregnant will have a
baby with Down syndrome is less than 1 in 1,000, but
the chance of having a baby with Down syndrome
increases to 1 in 400 for women who become pregnant
at age 35.
Approximately 98% of all fetuses with Turner syn-
drome result in miscarriage. Turner syndrome accounts
for about 10% of the total number of spontaneous
abortions in the United States. The incidence of Turner
syndrome in live female births is believed to be 1 in
2,500. Turner syndrome is a genetic disorder associated
with abnormalities of the X chromosome, occurring in
about 50 per 100,000 liveborn girls. The leading cause
of Down syndrome is nondisjunction of chromosome
21 occurring during the formation of gametes. The two
risk factors for maternal nondisjunction of chromo-
some 21 are increased maternal age and altered recom-
bination. Regarding sex chromosomes, XXY aneuploidy
is the most common disorder of sex chromosomes in
humans, with prevalence of 1 in 500 males.
When we talk about the incidence or prevalence of
a specific disease or syndrome, we should be very care-
ful not to mislead. There has been no overall change in
the prevalence of live infants born with Down syndrome.
Based on a malformation registry, Down syndrome
affected 1,188 pregnancies among 690,215 live births
in the United Kingdom (1.72 per 1,000 total births)
between 1985 and 2004 [3]. Therefore, Down syndrome
is not the most common human disease caused by 
a structural chromosome defect, but one of the most
common human diseases caused by a numerical chro-
mosome defect. Or, Down syndrome is the most com-
monly identified genetic form of mental retardation and
the leading cause of specific birth defects and medical
conditions [4].
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